Based on preclinical (animal and cellular) data only, inhibition of NNMT by 5-Amino-1MQ is theorised to: Raise intracellular NAD+ levels Activate SIRT1 and other sirtuins (proteins linked to metabolic regulation) Reduce fat cell (adipocyte) size and proliferation Improve insulin sensitivity These effects have been demonstrated in mouse models (Neelakantan et al., 2019), but robust human clinical trial data are currently absent
Im pregnant, can I have a B12 injection
In contrast, methylcobalamin and adenosylcobalamin are already in active states, allowing for immediate cellular use
We've analyzed hundreds of research protocols exploring peptide combinations, and the gap between theoretical synergy and practical implementation comes down to three factors most researchers overlook: receptor interaction profiles, dose timing windows, and compound stability under co-administration
Oral B12 relies on stomach acid, digestive enzymes, and a healthy gut lining